HemCon Medical, bolstered by high-tech bandage sales, hits the acquisition trail
HemCon Medical Technologies, a Portland, Ore., startup that makes and sells high-tech bandages, said it will acquire Alltracel Pharmaceuticals, a publicly traded but barely profitable Irish healthcare conglomerate that also has a wound-care focus. The release is here.
HemCon was only founded in 2001, but hit it big almost immediately with a new type of bandage, based on chitin found in shrimp shells, that binds to even the most severe wounds. As the Iraq War loomed,… Continue Reading
Life sciences briefing: Monday, Feb. 11, 2008
TODAY’S HEADLINES:
PolyRemedy, developer of robotic wound care, takes in $25M (release)
Bacchus Vascular gets $15M for clot-busting device (VentureWire)
Protein-evolution company Modular Genetics gets $1.2M (VentureWire)
PharmatrophiX gets $300K for Alzheimer’s disease prevention drugs (release)
Light Sciences Oncology withdraws IPO (Edgar)
Arizona’s Translational Accelerator launches $20M life-sciences fund (bizjournals.com)
Cornea-reshaper Avedro gets $7M (VentureWire)
Gastrotech Pharma gets $6M in wake of Lilly deal (VentureWire)
Biomaterials maker MiMedx goes public via reverse merger (release)
Acrongenomics to complete acquisition of Molecular Vision by the end of… Continue Reading
Life sciences briefing: Friday, Dec. 14, 2007
TODAY’S HEADLINES:
AcryMed, wound-healing specialist, sells itself to I-Flow for $25M (release)
Stent maker Devax pulls $85M IPO filing (Edgar)
Cempra Pharma gets $10M for anti-infective drugs (TechJournal South)
Genesis Genomics takes in C$312K for DNA-based diagnostics (GenomeWeb)
AcryMed, wound-healing specialist, sells itself to I-Flow for $25M — AcryMed, a Beaverton, Ore., device maker focused on bleeding control and wound healing, agreed to sell itself to I-Flow, a publicly traded maker of drug-delivery systems, for $25 million in cash. The… Continue Reading
Life sciences briefing: Tuesday, Dec. 4, 2007
Featured companies: AgraQuest, BridgeHealth, CardioMems, Collegium Pharmaceutical, Emergin, Entegrion, gDiapers, Precision Therapeutics, PregLem
UPDATED: Expanded items on Entegrion, Collegium, and gDiapers. Added CardioMems item. New items posted on AgraQuest (link), BridgeHealth (link) and Precision Therapeutics (link).
Entegrion draws $4.7M for bleeding control — Entegrion, a Research Triangle Park, N.C., biotech focused on products that stop bleeding, raised $4.7 million in a second funding round, VentureWire reports (subscription req’d). Investors included BD Ventures, Catalysta Partners and unnamed individuals.
Entegrion’s main product… Continue Reading
NeoMend pulls together $6M for wound healing
NeoMend, an Irvine, Calif., biomaterials company focused on wound care, raised $6 million in a third funding round, VentureWire reports (subscription required). Investors included Prospect Venture Partners, Sanderling Ventures and other unidentified venture capitalists. Four million dollars in bridge loans from Prospect and Sanderling also converted into equity.
NeoMend is developing an adhesive gel it calls Pro/PEG that can be sprayed or injected into surgical or other wounds to close them up. The company said the… Continue Reading